The Patent Finder

RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use (2024)

Lifeedit, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/IB2023/050560, filed Jan 23, 2023. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,398,385RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use
In force
 · High confidence
Life Edit Therapeutics, Inc.In force
High confidence
US 12,435,325RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use
In force
 · High confidence
Life Edit Therapeutics, Inc.In force
High confidence
US 12,473,539RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use
In force
 · High confidence
Life Edit Therapeutics, Inc.In force
High confidence
Application 19/268,552RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use
Pending
Not granted
Life Edit Therapeutics,Inc.PendingNot granted
Application 19/364,406RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use
Pending
Not granted
Life Edit Therapeutics, Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Lifeedit, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited